Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimoda, K.
Right arrow Articles by Harada, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimoda, K.
Right arrow Articles by Harada, M.
Related Collections
Right arrow Immunobiology
Right arrow Signal Transduction
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 March 2002, Vol. 99, No. 6, pp. 2094-2099

IMMUNOBIOLOGY

Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice

Kazuya Shimoda, Hiroko Tsutsui, Kenichi Aoki, Kouji Kato, Tadashi Matsuda, Akihiko Numata, Ken Takase, Tetsuya Yamamoto, Hideyuki Nukina, Tomoaki Hoshino, Yoshinobu Asano, Hisashi Gondo, Takashi Okamura, Seiichi Okamura, Kei-Ichi Nakayama, Kenji Nakanishi, Yoshiyuki Niho, and Mine Harada

From the First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Higashi-ku, Fukuoka, Japan; Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Higashi-ku, Fukuoka, Japan; Department of Immunology and Medical Zoology, Laboratory Host Defences Institute for Advanced Medical Sciences, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan; Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Japan; Pharmacosomatic Medicine, Faculty of Medicine, Kyushu University, Higashi-ku, Fukuoka, Japan; First Department of Internal Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan; Hematology Department, Internal Medicine, Kyushu Medical Center, Chuo-ku, Fukuoka, Fukuoka, Japan; Department of Molecular and Cellular Biology, Laboratory of Embryonic and Genetic Engineering, Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka, Japan; CREST, Japan Science and Technology Corporation (JST), Kawaguchi, Saitama, Japan; and Chihaya Hospital, Higashi-ku, Fukuoka, Japan.

Tyk2 is activated in response to interleukin-12 (IL-12) and is essential for IL-12-induced T-cell function, including interferon-gamma (IFN-gamma ) production and Th1 cell differentiation. Because IL-12 is a stimulatory factor for natural killer (NK) cell-mediated cytotoxicity, we examined whether tyk2 is required for IL-12-induced NK cell activity. IL-12-induced NK cell activity in cells from tyk2-deficient mice was drastically reduced compared to that in cells from wild-type mice. IL-18 shares its biologic functions with IL-12. However, the molecular mechanism of IL-18 signaling, which activates an IL-1 receptor-associated kinase and nuclear translocation of nuclear factor-kappa B, is different from that of IL-12. We next examined whether biologic functions induced by IL-18 are affected by the absence of tyk2. NK cell activity and IFN-gamma production induced by IL-18 were reduced by the absence of tyk2. Moreover, the synergistic effect of IL-12 and IL-18 for the production of IFN-gamma was also abrogated by the absence of tyk2. This was partially due to the absence of any up-regulation of the IL-18 receptor treated with IL-12, and it might suggest the presence of the cross-talk between Jak-Stat and mitogen-activated protein kinase pathways in cytokine signaling.

© 2002 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Nakamura, K. Shibata, H. Yamada, K. Shimoda, K. Nakayama, and Y. Yoshikai
Tyk2-Signaling Plays an Important Role in Host Defense against Escherichia coli through IL-23-Induced IL-17 Production by {gamma}{delta} T Cells
J. Immunol., August 1, 2008; 181(3): 2071 - 2075.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Li, H. Yamada, T. Yajima, R. Nakagawa, K. Shimoda, K. Nakayama, and Y. Yoshikai
Tyk2 Signaling in Host Environment Plays an Important Role in Contraction of Antigen-Specific CD8+ T Cells following a Microbial Infection
J. Immunol., April 1, 2007; 178(7): 4482 - 4488.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Sawaki, H. Tsutsui, N. Hayashi, K. Yasuda, S. Akira, T. Tanizawa, and K. Nakanishi
Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways
Int. Immunol., March 1, 2007; 19(3): 311 - 320.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Gingras, E. Parganas, A. de Pauw, J. N. Ihle, and P. J. Murray
Re-examination of the Role of Suppressor of Cytokine Signaling 1 (SOCS1) in the Regulation of Toll-like Receptor Signaling
J. Biol. Chem., December 24, 2004; 279(52): 54702 - 54707.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. Kamezaki, K. Shimoda, A. Numata, T. Matsuda, K.-I. Nakayama, and M. Harada
The role of Tyk2, Stat1 and Stat4 in LPS-induced endotoxin signals
Int. Immunol., August 1, 2004; 16(8): 1173 - 1179.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. Adachi, H. Tsutsui, E. Seki, H. Nakano, K. Takeda, K. Okumura, L. Van Kaer, and K. Nakanishi
Contribution of CD1d-unrestricted hepatic DX5+ NKT cells to liver injury in Plasmodium berghei-parasitized erythrocyte-injected mice
Int. Immunol., June 1, 2004; 16(6): 787 - 798.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
N. M. Tsuji, H. Tsutsui, E. Seki, K. Kuida, H. Okamura, K. Nakanishi, and R. A. Flavell
Roles of caspase-1 in Listeria infection in mice
Int. Immunol., February 1, 2004; 16(2): 335 - 343.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Suzuki, N.-J. Chen, D. G. Millar, S. Suzuki, T. Horacek, H. Hara, D. Bouchard, K. Nakanishi, J. M. Penninger, P. S. Ohashi, et al.
IL-1 Receptor-Associated Kinase 4 Is Essential for IL-18-Mediated NK and Th1 Cell Responses
J. Immunol., April 15, 2003; 170(8): 4031 - 4035.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. A. Gracie, S. E. Robertson, and I. B. McInnes
Interleukin-18
J. Leukoc. Biol., February 1, 2003; 73(2): 213 - 224.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020